Astrana Health (ASTH) Long-Term Investments (2016 - 2026)

Astrana Health (ASTH) has 11 years of Long-Term Investments data on file, last reported at $27.3 million in Q1 2026.

• Quarterly Long-Term Investments fell 28.28% year-over-year to $27.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.3 million (down 28.28% YoY) and the FY2025 annual result came in at $25.6 million, down 34.8% from the prior year.
• Long-Term Investments advanced to $27.3 million in Q1 2026 per ASTH's latest filing, from $25.6 million in the prior quarter.
• The five-year high for Long-Term Investments was $45.8 million in Q2 2023, with the low at $18.5 million in Q3 2025.
• Average Long-Term Investments over 5 years is $36.3 million, with a median of $38.5 million recorded in 2025.
• Year-over-year, Long-Term Investments surged 52.55% in 2024 and plunged 46.69% in 2025.
• Astrana Health's Long-Term Investments stood at $40.3 million in 2022, then slumped by 36.04% to $25.8 million in 2023, then soared by 52.55% to $39.3 million in 2024, then sank by 34.8% to $25.6 million in 2025, then grew by 6.32% to $27.3 million in 2026.
• Business Quant data shows ASTH's Long-Term Investments at $27.3 million in Q1 2026, $25.6 million in Q4 2025, and $18.5 million in Q3 2025.